Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trialPatrick G. Kehoe, Bernadette McGuinness, Ngoc Jade Thai et al.|The Lancet Neurology|2021Cited by 59
The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomesFergus Caskey, J. Athene Lane, Sunita Procter et al.|Trials|2022Cited by 39
Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s diseaseSandra Neumann, Emily J. Henderson, Jodi Taylor et al.|BMC Neurology|2021Cited by 22
Sertraline for anxiety in adults with a diagnosis of autism (STRATA): study protocol for a pragmatic, multicentre, double-blind, placebo-controlled randomised controlled trialDheeraj Rai, Nicola Wiles, Doug Webb et al.|Trials|2024Cited by 6
Sertraline for anxiety in adults with a diagnosis of autism (STRATA): Study protocol for a pragmatic, multicentre, double-blind, placebo-controlled randomised controlled trial.Dheeraj Rai, Nicola Wiles, Doug Webb et al.|Research Square|2023Cited by 3